Skip to main content
. 2019 May 2;55(1):131–141. doi: 10.3892/ijo.2019.4792

Figure 2.

Figure 2

BDKRB2 is overexpressed in cervical cancer tissues. (A) BDKRB2 was significantly upregulated in CC vs. normal samples in one dataset (Scotto Cervix Statistics) of the Oncomine online database (P<0.05). (B) The overexpression of BDKRB2 was further verified in CC tissues (n=15) and normal cervical tissues (n=9) by RT-qPCR (P<0.05). (C) Typical IHC images of BDKRB2 in CC, CIN and normal tissues. (D) The relevant cartogram of IHC scores of CC (n=44), CIN (n=12) and CON (n=8) tissues. BDKRB2 was notably overexpressed in CC (P<0.05) and CIN tissues (P<0.05) compared to normal cervical tissues. *P<0.05. n.s. non-statistical significance; BDKRB2, bradykinin B2 receptor; CC, cervical cancer; CIN, cervical intraepithelial neoplasia; NC, normal control.